{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    9,
    15,
    24,
    40,
    41,
    42,
    43,
    44
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Benefit-Risk Assessment Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "1.3",
        "sectionTitle": "Benefit-Risk Assessment",
        "description": "Added benefit-risk assessment for Sweden requirement"
      },
      {
        "id": "ref_2",
        "name": "Contraception Check Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.4.1",
        "sectionTitle": "Contraception Check",
        "description": "Reference for performing contraception checks during visits"
      },
      {
        "id": "ref_3",
        "name": "Medication Recording Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.13",
        "sectionTitle": "Nonstudy Vaccinations and Medications",
        "description": "Instructions for recording nonstudy vaccinations and medications"
      },
      {
        "id": "ref_4",
        "name": "Grade 4 Reaction Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "6.3",
        "sectionTitle": "Safety Reporting",
        "description": "Reference for reporting Grade 4 prompted local reactions or systemic events"
      },
      {
        "id": "ref_5",
        "name": "Pregnancy Test Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "7.1",
        "sectionTitle": "Urine Pregnancy Test",
        "description": "Reference for performing urine pregnancy tests for females of childbearing potential"
      },
      {
        "id": "ref_6",
        "name": "Fever Ranges Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Table 7",
        "sectionTitle": "Ranges for Fever",
        "description": "Reference for temperature ranges in clinical assessment"
      },
      {
        "id": "ref_7",
        "name": "AE/SAE Recording Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.1.4",
        "sectionTitle": "Recording AEs, SAEs, and NDCMCs",
        "description": "Instructions for recording adverse events and medical conditions"
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "Record nonstudy vaccinations and concomitant medications",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 16
      },
      {
        "id": "annot_2",
        "text": "Contraception check, if applicable",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 16
      },
      {
        "id": "annot_3",
        "text": "Obtain blood sample for immunogenicity (~50 mL)",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities",
        "pageNumber": 16
      },
      {
        "id": "annot_4",
        "text": "Use of prophylactic antipyretic/pain medication, while permitted, is not recommended on the day of investigational product administration",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "6.1.1",
        "pageNumber": 41
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "Amendment 2",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2019-02-11",
        "description": "Added benefit-risk assessment for Sweden and updated EudraCT number",
        "amendmentNumber": "2"
      },
      {
        "id": "ver_2",
        "versionNumber": "Amendment 1",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-09-25",
        "description": "Expanded age range for Cohort 1 and editorial changes",
        "amendmentNumber": "1"
      },
      {
        "id": "ver_3",
        "versionNumber": "Original Protocol",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2018-07-13",
        "description": "Initial release",
        "amendmentNumber": "N/A"
      }
    ],
    "summary": {
      "referenceCount": 7,
      "annotationCount": 4,
      "versionCount": 3
    }
  }
}